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Background:  Very few studies have investigated the feasibility and safety of transfemoral (TF) versus transaortic (TAo) TAVI.
methods and results:  Between January 2011 and December 2013, 279 cases of TF-TAVI and 221 cases of TAo-TAVI were included 
in the current analysis. The balloon-expandable (BE) prostheses were used in 196 (70%) cases of TF-TAVI and in 161 (73%) cases 
of TAo-TAVI (p=0.551). Other cases were performed using self-expandable (SE) prostheses. There were no significant differences in 
the device success rate (94% vs 94%, p=0.981) and 30-day mortality (8% vs 11%, p=0.296) between TF and TAo TAVI. Kaplan-Meier 
analysis revealed no significant difference in mid-term survival rate (log-rank p=0.595). Among cases with the BE prostheses, there were 
no significant differences in the device success rate (93% vs 93%, p=0.896) and 30-day mortality (8% vs 11%, p=0.637) between TF and 
TAo TAVI. Kaplan-Meier analysis revealed no significant difference in 1-year survival rate (log-rank p=0.679). Among cases with the SE 
prostheses, there were no significant differences in the device success rate (94% vs 93%, p=0.871) and 30-day mortality (8% vs 9%, 
p=0.885) between TF and TAo TAVI. Kaplan-Meier analysis revealed no significant difference in 1-year survival rate (log-rank p=0.735). 
The groups were also analyzed using a propensity-matching model (TF [n=101] versus TAo [n=101]). This model also indicated that there 
were no significant differences in the device success rate (94% vs 94%, p=0.988). Although there was no significant difference, 30-day 
mortality tended to be lower in TF-TAVI (6% vs 11%, p=0.140). Similarly, 1-year survival rate tended to be higher in TF-TAVI (83% vs 75%, 
p=0.127).
conclusion:  TF and TAo TAVI achieved similar device success, short-term and mid-term outcomes both with BE and SE prostheses. 
However, The outcome of TF-TAVI tended to be better compared to TAo-TAVI.
